ArticleFrontiers in medicine2025
CT radiomics combined with neural networks predict the malignant degree of pulmonary grinding glass nodules.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigates the use of CT radiomics combined with convolutional neural networks (CNN) to predict the malignancy of lung ground glass nodules (GGN), which are challenging to diagnose due to their ambiguous boundaries. The goal is to improve diagnostic accuracy and support personalized treatment planning. Methods: Retrospective data from 670 patients with pulmonary nodules (2019-2023) were analyzed. CT images were preprocessed using Gaussian filtering and manually segmented to define regions of interest (ROI). A CNN model was trained using MATLAB's Deep Learning Toolbox, and its performance was compared to the Mayo and Brock models. Results: Key predictors of malignancy included nodule diameter, volume, mean CT value, and consolidation-to-tumor ratio (CTR). The CNN-based model achieved an AUC of 0.887, with 82.4% sensitivity and 75.5% specificity, outperforming existing models (Mayo: AUC = 0.655; Brock: AUC = 0.574). Validation accuracy reached 85.07%. Conclusion: In this single-center retrospective study, integrating CT radiomics with CNN depicted promising potential for GGN malignancy prediction, though external validation remains necessary. These findings warrant verification in multicenter prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.